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background:  Cholesterol efflux capacity (CEC), a key HDL function, is a novel risk marker for atherosclerotic cardiovascular disease 
(ASCVD). We sought to determine whether CEC improves ASCVD risk prediction in addition to emerging risk markers such as family 
history of MI (FHMI) and coronary calcium (CAC).
Methods:  CEC, CAC, and FHMI were assessed in 1,972 participants free from CVD from the Dallas Heart Study, a probability-based 
multi-ethnic population sample. CEC was calculated by quantifying the capacity of a participant’s plasma depleted of apolipoprotein B to 
efflux BODIPY-cholesterol from macrophages. The primary outcome was time to first ASCVD event (n = 97): myocardial infarction, stroke, 
coronary revascularization and cardiovascular death (median follow-up 9.4 years).
Results:  The median age was 43, with 56% women and 46% Blacks. CEC was inversely associated with incident ASCVD in a fully-
adjusted model including traditional risk factors, FHMI and CAC (HR per 1SD: 0.58, 95% CI 0.46 - 0.73). Addition of CEC did not 
significantly increase the C-statistic (0.83 to 0.85; p=0.09) but did improve net reclassification index (0.48, 95%CI 0.25-0.71) and integrated 
discrimination improvement (0.03, p=0.007). In stratified analyses, CEC inversely associated with incident ASCVD even among those with 
prevalent CAC and those with FHMI (Figure).
conclusion:  CEC improves risk prediction of incident ASCVD independent of FHMI and CAC. Further studies assessing the clinical utility 
of CEC are warranted.
